Preventing Hospitalization, Admissions or Death With a Vaccine

Fiser's clinical trial found 89% reduction in risk of hospitalization and death for unvaccinated people. In the standard risk group, which included those who were vaccinated but didn't have a high risk factor, there was no significant benefit from paxlipi. So it's not as clear from the standard risk data what exactly paxlip i has to offer vaccinated people.